Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) FCF Margin (2016 - 2025)

Apyx Medical's FCF Margin history spans 15 years, with the latest figure at 14.64% for Q4 2025.

  • For Q4 2025, FCF Margin rose 774.0% year-over-year to 14.64%; the TTM value through Dec 2025 reached 17.25%, up 2177.0%, while the annual FY2025 figure was 17.25%, 2177.0% up from the prior year.
  • FCF Margin reached 14.64% in Q4 2025 per APYX's latest filing, up from 31.49% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 29.41% in Q3 2023 to a low of 62.24% in Q1 2024.
  • Average FCF Margin over 5 years is 28.51%, with a median of 31.7% recorded in 2021.
  • Peak YoY movement for FCF Margin: skyrocketed 12405bps in 2021, then tumbled -6939bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 0.7% in 2021, then tumbled by -5182bps to 37.05% in 2022, then skyrocketed by 58bps to 15.72% in 2023, then tumbled by -42bps to 22.37% in 2024, then surged by 35bps to 14.64% in 2025.
  • Per Business Quant, the three most recent readings for APYX's FCF Margin are 14.64% (Q4 2025), 31.49% (Q3 2025), and 13.17% (Q2 2025).